NCT03530800View on ClinicalTrials.gov

Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

July 20, 2021

Study Completion Date

November 1, 2021

Conditions
TrichotillomaniaSkin-Picking
Interventions
DRUG

Dronabinol

Dronabinol for 10 weeks (5mg per day first 2 weeks, 10mg per day second two weeks, 15mg per day last six weeks)

DRUG

Placebo

Placebo for 10 weeks

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03530800 - Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors | Biotech Hunter | Biotech Hunter